Author:
Hall Peter S.,McCabe Christopher,Brown Julia M.,Cameron David A.
Reference52 articles.
1. ISPOR. International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Directory of health technology assessment organisations worldwide. [accessed April 2010].
2. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle;Taylor;BMJ,2004
3. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers;Thorpe;J Clin Epidemiol,2009
4. Herceptin and early breast cancer: a moment for caution;Editorial;Lancet,2005
5. BBC. Herceptin: was patient power key? 2006. [accessed December 2009].
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献